Our patent system is definitely broken. You won’t hear an argument for me on that.
We also have a problem when generics are being created by companies that actually own the brand name. They’re only going o undercut their brand so much. In the case of the original drug going to 750… they could have made a generic but there was no incentive to do so. The delivery system for EpiPen is patented but the drug isn’t and there is a competing product. What;s wrong with the competing product… oh there have been issues there too.
Look, i’m all for private companies making money, but I am not for evergreen patents, and I am definitely against brand names owning the companies that make the generics. If the private market won’t provide a valid method for generic creation, then that seems like an area we could consider for the public market to take care of. If the patent system were legit and sufficient, and I agree there is a problem there now, that would provide plenty of time for them to have their time with a profit generating product and just realize once that’s over their going to face very cheap generics from public entities if necessary since the shenanigans in the private sector are not fulfilling the function.